Skip to main content
. 2018 Oct 25;2018:9853192. doi: 10.1155/2018/9853192

Table 13.

Serum YKL-40 levels (ng/ml) in patients with inflammation, tissue remodeling, or fibrosis [201].

Disease Median serum YKL-40 (ng/l) Reference
Viral hepatitis 83 [202]
Noncirrhotic fibrosis 158
Posthepatitis cirrhosis 204
Rheumatoid arthritis 110 [203]
Streptococcus pneumoniae bacteremia 342 [200]
Osteoarthritis 112 [204]
UC, severe 59 [205]
CD, severe 59
Pulmonary sarcoidosis 201 [206]
Asthma 92 [207]